Dow Jones

40,003.59

0.34%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Big Cypress Acquisition Corporation (BCYP)
Big Cypress Acquisition Corporation (BCYP) Noticias

BCYP

Big Cypress Acquisition (BCYP)

Big Cypress Acquisition Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BCYP

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/06/2023	07:51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
19/05/2023	08:30	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
15/05/2023	16:06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
10/05/2023	05:06	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
09/05/2023	15:14	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
28/04/2023	15:48	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
14/04/2023	16:00	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
05/04/2023	16:02	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
16/03/2023	15:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
03/02/2023	15:58	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
16/12/2022	15:35	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
18/11/2022	08:16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
23/08/2022	05:03	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
11/02/2022	14:40	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
01/02/2022	15:04	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
22/11/2021	15:06	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
22/11/2021	13:31	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
15/11/2021	16:25	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
02/11/2021	05:03	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
25/10/2021	06:39	GlobeNewswire Inc.	SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company	NASDAQ:BCYP	Big Cypress Acquisition Corporation
22/10/2021	15:19	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
21/10/2021	06:00	PR Newswire (US)	Big Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB Biotherapeutics	NASDAQ:BCYP	Big Cypress Acquisition Corporation
19/10/2021	08:52	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
07/10/2021	08:29	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BCYP	Big Cypress Acquisition Corporation
06/10/2021	06:00	Business Wire	SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021	NASDAQ:BCYP	Big Cypress Acquisition Corporation
04/10/2021	06:00	Business Wire	SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19	NASDAQ:BCYP	Big Cypress Acquisition Corporation
29/09/2021	11:30	Business Wire	SABバイオセラピューティクス、SAB-185が肯定的なDSMB評価を受け、COVID-19を治療するためのNIHスポンサーACTIV-2試験の第3相に移行したと発表	NASDAQ:BCYP	Big Cypress Acquisition Corporation
28/09/2021	06:00	Business Wire	SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer	NASDAQ:BCYP	Big Cypress Acquisition Corporation
25/09/2021	03:39	Business Wire	SAB Biotherapeutics: SAB-185 zur Behandlung von COVID-19 erhält positive DSMB-Stellungnahme und erreicht Phase 3 in NIH-gesponserter Studie ACTIV-2	NASDAQ:BCYP	Big Cypress Acquisition Corporation
24/09/2021	17:01	Business Wire	SAB Biotherapeutics annonce que le SAB-185 a reçu une très bonne évaluation d'un comité de contrôle des données (CICD) et qu'il progresse désormais vers la Phase 3 dans le cadre de l'essai ACTIV-2 sponsorisé par les National Institutes of Health...	NASDAQ:BCYP	Big Cypress Acquisition Corporation